FI107018B - Dermatologinen käyttö ja valmiste - Google Patents

Dermatologinen käyttö ja valmiste Download PDF

Info

Publication number
FI107018B
FI107018B FI20000818A FI20000818A FI107018B FI 107018 B FI107018 B FI 107018B FI 20000818 A FI20000818 A FI 20000818A FI 20000818 A FI20000818 A FI 20000818A FI 107018 B FI107018 B FI 107018B
Authority
FI
Finland
Prior art keywords
psoriasis
effect
spot
treatment
thyroid hormone
Prior art date
Application number
FI20000818A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20000818A0 (fi
Inventor
Pekka Untamo Heino
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of FI20000818A0 publication Critical patent/FI20000818A0/fi
Priority to FI20000818A priority Critical patent/FI107018B/fi
Priority to CA002405425A priority patent/CA2405425A1/en
Priority to DE10196025T priority patent/DE10196025T1/de
Priority to GB0222880A priority patent/GB2377380B/en
Priority to EP01907581A priority patent/EP1274416A1/en
Priority to ES200250061A priority patent/ES2193003B1/es
Priority to CH01666/02A priority patent/CH695983A5/de
Priority to AU2001235506A priority patent/AU2001235506A1/en
Priority to PCT/FI2001/000100 priority patent/WO2001076589A1/en
Priority to DK200201483A priority patent/DK200201483A/da
Priority to JP2001574107A priority patent/JP2003530349A/ja
Priority to US10/239,882 priority patent/US20030144359A1/en
Application granted granted Critical
Publication of FI107018B publication Critical patent/FI107018B/fi
Priority to SE0202886A priority patent/SE0202886L/
Priority to NO20024810A priority patent/NO20024810L/no
Priority to US11/198,133 priority patent/US20050272817A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
FI20000818A 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste FI107018B (fi)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste
CH01666/02A CH695983A5 (de) 2000-04-06 2001-02-05 Tetraiodthyropropionsäure oder Tetraiodthyroessigsäure zur Herstellung eines dermatologischen Präparates.
PCT/FI2001/000100 WO2001076589A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation
GB0222880A GB2377380B (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation
EP01907581A EP1274416A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation
ES200250061A ES2193003B1 (es) 2000-04-06 2001-02-05 Uso dermatologico y preparacion dermatologica.
CA002405425A CA2405425A1 (en) 2000-04-06 2001-02-05 Dermatological preparations containing thyronine derivatives and uses thereof
AU2001235506A AU2001235506A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation
DE10196025T DE10196025T1 (de) 2000-04-06 2001-02-05 Dermatologische Verwendung und ein dermatologisches Präparat
DK200201483A DK200201483A (da) 2000-04-06 2001-02-05 Dermatologisk anvendelse og dermatologisk præparat
JP2001574107A JP2003530349A (ja) 2000-04-06 2001-02-05 皮膚病用の使用方法及び皮膚病用薬剤
US10/239,882 US20030144359A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation
SE0202886A SE0202886L (sv) 2000-04-06 2002-10-01 Dermatologisk användning och dermatologisk beredning
NO20024810A NO20024810L (no) 2000-04-06 2002-10-04 Dermatologisk preparat samt anvendelse derav
US11/198,133 US20050272817A1 (en) 2000-04-06 2005-08-08 Dermatological use and a dermatological preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000818 2000-04-06
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste

Publications (2)

Publication Number Publication Date
FI20000818A0 FI20000818A0 (fi) 2000-04-06
FI107018B true FI107018B (fi) 2001-05-31

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste

Country Status (14)

Country Link
US (2) US20030144359A1 (enExample)
EP (1) EP1274416A1 (enExample)
JP (1) JP2003530349A (enExample)
AU (1) AU2001235506A1 (enExample)
CA (1) CA2405425A1 (enExample)
CH (1) CH695983A5 (enExample)
DE (1) DE10196025T1 (enExample)
DK (1) DK200201483A (enExample)
ES (1) ES2193003B1 (enExample)
FI (1) FI107018B (enExample)
GB (1) GB2377380B (enExample)
NO (1) NO20024810L (enExample)
SE (1) SE0202886L (enExample)
WO (1) WO2001076589A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
AU2004273986B2 (en) * 2003-09-15 2010-04-22 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use in angiogenesis
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
WO2007035612A2 (en) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Polyphenol conjugates as rgd-binding compounds and methods of use
EP2120913B1 (en) 2006-12-22 2015-01-21 NanoPharmaceuticals LLC Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
WO2010075332A1 (en) * 2008-12-23 2010-07-01 Charitable Leadership Foundation Small molecule ligands of the integrin rgd recognition site and methods of use
US9180107B2 (en) 2009-03-31 2015-11-10 Nanopharmaceuticals Llc Combination treatment of cancer with cetuximab and tetrac
WO2010148007A2 (en) 2009-06-17 2010-12-23 Ordway Research Institute, Inc. Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
AU2017279536A1 (en) 2016-06-07 2018-12-20 Nanopharmaceuticals, Llc Non-cleavable polymer conjugated with αvβ3 integrin thyroid antagonists
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
CA2184002A1 (en) * 1994-02-23 1995-08-31 Jeffrey M. Blaney Method and compositions for increasing the serum half-life of pharmacologically active agents
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
AU780503B2 (en) * 1999-04-26 2005-03-24 Albert Burger Pharmaceutical compositions of tetrac and methods of use thereof
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
DE10196025T1 (de) 2003-03-13
EP1274416A1 (en) 2003-01-15
SE0202886D0 (sv) 2002-10-01
FI20000818A0 (fi) 2000-04-06
NO20024810L (no) 2002-12-06
GB2377380B (en) 2004-07-14
US20030144359A1 (en) 2003-07-31
AU2001235506A1 (en) 2001-10-23
DK200201483A (da) 2002-10-03
ES2193003A1 (es) 2003-10-16
CA2405425A1 (en) 2001-10-18
GB0222880D0 (en) 2002-11-13
US20050272817A1 (en) 2005-12-08
CH695983A5 (de) 2006-11-15
SE0202886L (sv) 2002-12-02
WO2001076589A1 (en) 2001-10-18
GB2377380A (en) 2003-01-15
NO20024810D0 (no) 2002-10-04
ES2193003B1 (es) 2005-02-01
JP2003530349A (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
JP3706792B2 (ja) 局所用亜鉛組成物および使用方法
JP7322077B2 (ja) 連結組職中のエラスチン及びコラーゲン生合成増進用組成物
JPH06107542A (ja) 医薬組成物
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
US20030144359A1 (en) Dermatological use and a dermatological preparation
RU2199319C1 (ru) Композиции для лечения кожных заболеваний
PT723778E (pt) Composicao indutora de apoptose compreendendo um factor que aumenta a taxa intracelular de metional ou de malondialdeido
US6380255B1 (en) Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
BRPI0111142B1 (pt) Use of derivatives of biguanide or of its pharmaceutically acceptable salts thereof for manufacture of a medicinal product having a healing effect
JP2003530349A5 (enExample)
US20070154532A1 (en) Compositions comprising vitamins and/or derivatives thereof stablished with olea europea extract and/or ionene polymers
WO2017009486A1 (en) Topical compositions
TW201236677A (en) Composition for topical use for treating skin disorders
JPH0399019A (ja) 毛細血管脆弱の処置の局所的使用のための製薬学的組成物
US20060205699A1 (en) Topical treatment for psoriasis
WO2012088597A1 (en) Nitric oxide amino acid esters for enhancement of physical or muscular performance and the treatment of muscular or neuromuscular diseases
JPH03112912A (ja) 化粧料組成物
JP2014210762A (ja) 皮脂分泌抑制剤
JP2781982B2 (ja) 皮膚外用剤
DE69426986T2 (de) Behandlung von laminitis
CN1938009A (zh) 包含用齐墩果提取物和/或紫罗烯聚合物稳定的维生素和/或其衍生物的组合物
WO2018012157A1 (ja) メラニン産生抑制剤、美白剤、線維芽細胞活性化剤、コラーゲン及び／又はエラスチン産生促進剤、及びシワ改善剤
JPH05509291A (ja) フェニルアミン系脱色素、抗黒色腫剤
CH630803A5 (en) Medicinal preparations, for the treatment of hypercholesterolaemia in particular
US11780883B2 (en) Derived peptide of lactoferrin and method thereof for promoting and/or increasing lipid synthesis

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: HEINO

Free format text: HEINO